Ro vs Hims for GLP-1 Weight Loss: Which One Is Actually Worth Your Money in 2026?
Transparency note: This page contains affiliate links. If you sign up through our links, we may earn a commission — but it doesn't change what you pay or what we recommend. We recommend the best option for your situation, even when it pays us less. Read our full editorial policy.
This content is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any weight loss medication.
If you're comparing Ro vs Hims for GLP-1 weight loss, here's the short answer: they win in completely different situations, and picking the wrong one could cost you hundreds of dollars or stick you with a program that doesn't fit how you want to pay, what medication you need, or whether your insurance can help.
We checked both platforms' official pricing pages, support documents, medication offerings, cancellation policies, and terms of service — then built this guide around the five questions that actually decide which one is better for you:
- What will I really pay — today, in month 3, and over a year?
- Am I getting an FDA-approved medication or a compounded one?
- Can insurance help, or am I fully cash-pay?
- Can I cancel or switch without getting trapped?
- Which platform actually fits my specific situation?
The Quick Verdict
Pick Ro if:
You have commercial insurance that might cover a GLP-1, you want a free personalized coverage report before committing, or you want a clear FDA-approved cash-pay path (Wegovy pill, Wegovy pen, or Zepbound vials). Ro's insurance concierge can help fight for coverage, and if your plan cooperates, your medication cost drops to a copay — potentially making Ro the cheapest total option by a wide margin.
Pick Hims if:
You're paying cash with no insurance, you want the simpler no-membership-fee pricing model, you want oral medication options beyond injections, or you're comfortable paying upfront for a multi-month plan to lock in a lower monthly rate.
Pick neither if:
Your primary care doctor can prescribe a GLP-1 your insurance covers with a low copay — that's almost always the cheapest path. Neither platform bills Medicare or Medicaid for the program. Ro says it currently cannot coordinate GLP-1 coverage for government insurance plans, though some cash-pay options may still be available. Hims is cash-pay only and does not require insurance.
The key cost difference: Ro charges a separate monthly membership ($39 first month, $149/month after) plus medication costs. Hims bundles everything into the medication price with no membership fee — but the lower advertised monthly rates require upfront payment for multi-month plans. Those are two fundamentally different payment models, and which one saves you money depends entirely on your insurance situation and how long you plan to stay on treatment.
Important 2026 context
The GLP-1 landscape shifted significantly in early 2026. On March 9, 2026, Hims and Novo Nordisk announced a deal under which Hims will stop advertising and marketing compounded semaglutide, offer it only on a limited scale when a provider determines it is clinically necessary, and bring branded Ozempic and Wegovy (both injectable and oral) to the platform. Novo Nordisk dismissed its patent infringement lawsuit against Hims as part of the agreement. Ro's current public pricing page emphasizes FDA-approved branded options. This guide reflects the current reality as of March 16, 2026.
How Do Ro and Hims Actually Compare? (Side-by-Side)
We verified every row against each platform's official pricing and support pages — not third-party aggregators.
| Feature | Ro Body Program | Hims Weight Loss | What This Means for You |
|---|---|---|---|
| Best for | Insurance users, FDA-approved meds, comprehensive support | Cash-pay simplicity, oral options, no membership fee | Different strengths — neither is universally "better" |
| Monthly membership fee | $39 first month, then $149/mo | No membership fee | Ro's fee adds up ($1,740/year) but includes clinical services |
| Medication included in membership? | No — billed separately | Yes — price is all-in | Hims' price is what you pay. Ro's total = membership + med |
| Compounded semaglutide (injectable) | Ro emphasizes FDA-approved options | Starting ~$199/mo (6-mo plan) — limited scale going forward | Hims is cheaper here while available, but access is narrowing |
| Wegovy pen (branded, injectable) | $199/mo intro for first 2 months (0.25–0.5 mg, through Mar. 31), then $349/mo | $599/mo on a 6-mo plan (paid upfront); all dosages same price | Compare total cost including Ro's membership fee |
| Wegovy pill (branded, oral) | $149/mo for 1.5 mg and 4 mg (4 mg valid through Apr. 15, then $199/mo); $299/mo for 9 mg and 25 mg | Coming via Novo partnership — pricing and timing TBD | Ro has a head start here |
| Zepbound vials (tirzepatide) | $299/mo (2.5 mg), $399/mo (5 mg), $449/mo (7.5–15 mg with manufacturer offer) | Listed but no public cash-pay pricing displayed | Ro has the clearer public Zepbound cash-pay path |
| Oral medication kits (non-GLP-1) | Not offered | Starting ~$69/mo (multi-month). Compounded, not FDA-approved. May include metformin, bupropion, topiramate, naltrexone, B12. | Hims has an oral non-injection option Ro doesn't |
| Anti-nausea medication | No | Yes — ondansetron at no extra cost if prescribed | Nice Hims perk, especially first weeks |
| Insurance for medication | Membership is cash-pay. Concierge helps with prior auth for eligible GLP-1 medication billed through your plan. | No — cash-pay only | Often the single biggest cost factor |
| Free insurance coverage check | Yes — personalized report before you commit | No | Ro lets you check before paying anything |
| Lab testing | Provider-ordered metabolic testing at Quest included; at-home kit $75 | Not routinely included; may be ordered at additional cost | Ro's standard labs are built into the membership |
| Provider check-ins | Monthly + unlimited messaging | Unlimited online follow-ups + 24/7 messaging | Similar access, but Ro is more structured |
| Coaching & lifestyle support | Nurse coaching, nutrition, exercise curriculum | App-based nutrition + behavioral programs, meal replacement bars/shakes | Ro is more hands-on; Hims is more self-guided |
| HSA/FSA eligible | Yes — submit receipt for reimbursement | Yes — pay regular card, submit for reimbursement | Both qualify, but neither takes the card directly |
| State availability | All 50 states + D.C.; specific treatment availability may vary | Platform in all 50 states; GLP-1s not in all states (46 states + D.C. for compounded semaglutide) | Check Hims' state list before starting |
| Medicare/Medicaid | Does not bill government insurance; cannot currently coordinate GLP-1 coverage for government plans | Cash-pay only; does not require or accept insurance | Neither bills government insurance |
| Cancel policy | Cancel anytime, 48hrs before billing date; membership nonrefundable once charged | Cancel before next billing cycle; no refunds on prepaid months | Ro bills monthly; Hims pre-collects for multi-month plans |
| Payment structure | Monthly billing | Upfront payment for plan length | Different commitment models |
| LegitScript certified | Yes | Yes | Both verified by independent certification body |
Pricing verified against ro.co/weight-loss/pricing/ and hims.com/weight-loss on March 16, 2026. Prices change frequently — verify directly with each provider before committing.
Pick Ro If You're in One of These Situations
Your insurance might cover a GLP-1
This is where Ro pulls away from Hims — and it's not close.
Ro's insurance concierge submits prior authorization paperwork to your insurer, handles denials, and explores alternative medications if your first choice isn't covered. This service is included in the membership at no extra cost. If your commercial insurance covers Wegovy or Zepbound, your out-of-pocket medication cost drops to your plan's copay. With Novo Nordisk's manufacturer savings card, commercially insured patients may pay as little as $0–$25/month for Wegovy.
Run the numbers: $149/month membership + a $25 copay = $170/month total. That's less than any cash-pay option on either platform.
Hims doesn't work with insurance at all. If you have commercial coverage (or think you might), choosing Hims means paying full cash price regardless of what your plan would cover.
Ro also offers a free GLP-1 insurance checker — a personalized coverage report that tells you what your plan covers, your estimated copay, prior authorization requirements, and medication supply details — before you pay anything. That alone is worth checking before you decide.
You want a clear FDA-approved cash-pay path
Even without insurance, Ro currently lists straightforward pricing for FDA-approved medications:
- Wegovy pill: $149/mo for 1.5 mg; $149/mo for 4 mg (through April 15, 2026, then $199/mo); $299/mo for 9 mg and 25 mg
- Wegovy pen: $199/mo for the first 2 months at 0.25–0.5 mg (through March 31, 2026); $349/mo thereafter
- Zepbound vials: $299/mo (2.5 mg), $399/mo (5 mg), $449/mo (7.5–15 mg with manufacturer offer)
All of the above require the $149/mo Ro Body membership on top. But you know exactly what you're getting: FDA-approved medications sourced through NovoCare Pharmacy and LillyDirect, with lab testing, provider oversight, and dose management included.
You want Zepbound (tirzepatide) specifically
Hims lists Zepbound on its weight-loss page, but does not currently display public cash-pay pricing for it the way Ro does. Ro offers Zepbound vials through a LillyDirect partnership with transparent dose-by-dose pricing. If you want a clear, priced path to tirzepatide right now, Ro is the stronger option between these two.
You want to avoid large upfront payments
Ro bills monthly. The membership renews each month, and medication is billed as prescribed. You're never asked to pay for six or ten months upfront to get a better rate. For some people, that monthly flexibility matters more than the membership fee.
Pick Hims If You're in One of These Situations
You're paying cash and want simpler bundled pricing
Hims doesn't charge a membership fee. The price you see is the price you pay — medication, consultation, and follow-ups are bundled together. For someone without insurance who doesn't want to think about separate line items, that simplicity is appealing.
Current pricing:
- Compounded semaglutide (injectable): Starting ~$199/mo on a 6-month plan paid upfront — availability narrowing per March 2026 Novo deal
- Oral medication kits: Starting ~$69/mo on a multi-month plan paid upfront. Compounded drugs, not FDA-approved. May include metformin, bupropion, topiramate, naltrexone, and B12.
- Wegovy (branded, FDA-approved): $599/mo on a 6-month plan paid upfront; all dosages cost the same
- Also listed: Ozempic, Mounjaro, Zepbound, and generic liraglutide
The catch: those lower monthly rates come from paying upfront for multi-month commitments. The 6-month compounded semaglutide plan means paying approximately $1,194 upfront. That's real money before you know whether the medication agrees with your body.
You want oral medication options
Hims offers something Ro doesn't: oral medication kits that don't require injections. These are not GLP-1s — they're compounded combinations of medications like metformin, bupropion, naltrexone, topiramate, and B12 designed for weight management. These oral kits are compounded drug products and are not approved or evaluated for safety, effectiveness, or quality by the FDA. Starting at roughly $69/month on a multi-month plan, they're the lowest-cost entry point in this comparison.
Hims is also bringing branded oral Wegovy to the platform through its new Novo Nordisk partnership, though pricing and availability details haven't been announced yet.
You don't want to pay a membership fee on top of medication
Ro's $149/month membership is $1,740 per year. If you're not using the coaching, labs, and insurance concierge — or if you don't have insurance — that fee sits on top of your medication cost and adds meaningful expense. Hims eliminates that layer entirely. What you see is what you pay.
You want anti-nausea support included
GLP-1 side effects hit hardest in the first few weeks — nausea is the most common complaint. Hims includes ondansetron (brand name Zofran) at no additional cost if your provider determines you need it. Ro does not include anti-nausea medication in the program. That's a small but real quality-of-life detail, especially for the first month or two.
When Neither Ro nor Hims Is the Right Choice
We're not going to pretend these are the only two options. There are situations where both platforms are the wrong answer:
Your primary care doctor can prescribe a covered GLP-1.
If your insurance covers Wegovy or Zepbound with a reasonable copay, going through your regular doctor is almost always cheaper than any telehealth platform. You avoid membership fees, you get in-person oversight, and your existing medical team already knows your history.
You need in-person care or complex medical follow-up.
Both platforms are telehealth-first. If you have significant comorbidities, a complicated medication history, or need hands-on clinical monitoring, a local obesity medicine specialist or endocrinologist is the safer choice.
You're on Medicare, Medicaid, or TRICARE.
Neither Ro nor Hims bills government insurance for their programs. Ro says it currently cannot coordinate GLP-1 coverage for government insurance plans. Hims is cash-pay only. If government insurance is your coverage, talk to your doctor about GLP-1 access through your plan, or look into patient assistance programs directly from Novo Nordisk and Eli Lilly.
You're not comfortable with long-term medication use.
GLP-1s work while you take them. Research consistently shows that most people regain weight after stopping. If you're not ready for an ongoing medication commitment, a conversation with your doctor about all your options makes more sense than signing up for a subscription you'll cancel in two months.
See our full guide to GLP-1 providers beyond Ro and Hims.
What Will You Actually Pay? The Real Math Nobody Shows You
This is where most comparison pages fail you. They quote "starting at" prices without explaining that doses go up, intro pricing expires, membership fees compound, and upfront commitments change the math entirely.
Understanding the Two Pricing Models
Ro's Model
Separates the membership fee ($39 first month, $149/month ongoing) from medication pricing. You pay two charges: one for the program, one for the drug. The value of the membership — labs, coaching, insurance concierge, provider access — is real, but so is the cost.
Hims' Model
Bundles everything into the medication price. No separate membership fee. But the advertised monthly rates assume you're paying upfront for a multi-month plan. A 6-month compounded semaglutide plan at ~$199/month means ~$1,194 due today.
Scenario A: Branded Wegovy Pen (Injectable), Cash-Pay
Ro
- Month 1: $39 + $199 (intro) = $244
- Month 2: $149 + $199 (intro) = $344
- Months 3–6: $149 + $349/mo = $494/month
- 6-month total: ~$2,578
$199/mo intro pricing valid through March 31, 2026 for 0.25–0.5 mg doses only.
Hims
- $599/mo on a 6-month plan paid upfront
- All Wegovy dosages cost the same
- 6-month total: $3,594 due today
Winner: Ro — even with the membership fee, Ro's total is approximately $1,000 less over six months for branded Wegovy pen.
Scenario B: Branded Wegovy Pill (Oral Semaglutide), Cash-Pay
Ro
- Month 1: $39 + $149 (1.5 mg) = $194
- Months 2–6: $149 + $149 = $294/month
- Higher doses (9–25 mg): $149 + $299 = $444/month
- 6-month total (staying at 1.5 mg): ~$1,664
- 6-month total (escalating to 9+ mg): ~$2,414+
Hims
Branded oral Wegovy is coming to Hims through the Novo partnership, but pricing and timeline have not been publicly announced.
Winner: Ro by default — they have it available and priced now.
Scenario C: With Commercial Insurance Covering Medication
Ro
- Month 1: $39 + copay ($0–$25/mo with manufacturer savings card)
- Months 2–6: $149 + copay ($0–$25)
- 6-month total: ~$870–$1,020
Membership is cash-pay only; insurance may cover the medication.
Hims
Does not work with insurance. Cash-pay pricing applies regardless of your coverage.
Winner: Ro — overwhelmingly. If your insurance covers even part of the medication cost, Ro's total cost drops well below anything Hims can offer.
Scenario D: Compounded Semaglutide, Cash-Pay (While Still Available)
Ro
Ro's current public pricing page emphasizes FDA-approved branded options. Compounded semaglutide is not prominently listed.
Hims
- ~$199/month on a 6-month plan = $1,194 paid upfront
- All-in price — no additional fees
- Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA.
Winner: Hims, if you can still access compounded semaglutide in your state. But be aware — availability is narrowing significantly.
Scenario E: Oral Medication Kits (Non-GLP-1), Cash-Pay
Hims: ~$69/month on a multi-month plan paid upfront. These are compounded drug products and are not FDA-approved. Includes combinations of metformin, bupropion, naltrexone, topiramate, and B12.
Ro: Does not offer non-GLP-1 oral medication kits.
Winner: Hims by default — Ro doesn't compete here. Note that oral kits are not GLP-1 medications and work through different mechanisms.
The HSA/FSA Factor
Both platforms are generally HSA/FSA eligible since they involve physician-prescribed medical treatment. However, neither currently accepts HSA/FSA cards directly at checkout. Both recommend paying with a regular card and submitting for reimbursement afterward. At a 30% combined tax rate, using pre-tax dollars effectively reduces your cost by roughly 30%. See all HSA-friendly GLP-1 providers.
Hidden Costs to Watch
- Ro home blood collection kit: $75 if you prefer at-home over going to Quest Diagnostics (standard metabolic test at Quest is included)
- Hims labs: If your provider orders lab work, you'll pay out of pocket
- Dose escalation on Ro: pricing varies by dose — as you titrate up, medication costs increase. On Hims' Wegovy plans, all dosages cost the same — no price increase at higher doses.
- Promo expiration dates: Ro's Wegovy pen intro pricing ends March 31, 2026. Ro's Wegovy pill 4 mg pricing of $149/mo ends April 15, 2026. After those dates, prices increase.
- Cancellation timing: If you miss the 48-hour cancellation window on either platform, you'll be charged for the next period.
Pricing verified against official Ro and Hims pages on March 16, 2026. The GLP-1 pricing landscape is changing rapidly. Always verify current pricing directly before making a financial commitment.
What Medication Are You Actually Comparing?
This trips people up more than anything. "Ro vs Hims" isn't really a comparison unless you know which medication path you're comparing on each platform. They don't offer the same menu.
What Ro Currently Offers
- Wegovy (semaglutide) — injectable pen: Weekly injection. Multiple dose-based price points.
- Wegovy (semaglutide) — oral pill: Daily pill. Multiple dose-based price points. Only available as cash-pay through Ro.
- Ozempic (semaglutide) — injectable: Approved for type 2 diabetes, prescribed off-label for weight loss.
- Zepbound (tirzepatide) — vials: Dual GIP/GLP-1 agonist. Available through Ro's LillyDirect partnership.
What Hims Currently Offers
- Compounded semaglutide — injectable: Starting at ~$199/mo. Limited scale going forward. Not FDA-approved.
- Oral medication kits (non-GLP-1): Starting at ~$69/mo. Compounded, not FDA-approved.
- Branded FDA-approved GLP-1s: Wegovy, Ozempic, Mounjaro, Zepbound, generic liraglutide listed.
- Compounded oral semaglutide pill: Announced Feb 2026 at ~$49/mo but pulled within days after FDA pressure.
Why This Matters: It's Not Always Apples to Apples
When someone says "Hims is cheaper than Ro," they're often comparing Hims' compounded semaglutide to Ro's branded Wegovy. Those are not the same product. Compounded semaglutide is not FDA-approved. Branded Wegovy is FDA-approved and manufactured under strict federal oversight by Novo Nordisk.
The real comparison is: for the same type of medication and the same approval status, what does each platform charge — and what do you get beyond the pill or injection?
Oral vs. Injectable: A Quick Framework
- Wegovy pill (FDA-approved oral semaglutide for weight loss): Available through Ro now at $149–$299/mo depending on dose. Coming to Hims via Novo partnership (pricing TBD).
- Hims oral kits (compounded, non-GLP-1): Available now. Lower cost, different mechanism, not FDA-approved, different expectations.
- Compounded oral semaglutide: Hims pulled its compounded oral pill in February 2026. Not available through Ro.
If you want an FDA-approved oral GLP-1 specifically, Ro is your current option between these two platforms. If you want any oral weight loss medication and don't specifically need a GLP-1, Hims gives you more choices — with the understanding that those oral kits are compounded products that are not FDA-approved.
Is Compounded Semaglutide Going Away? (And What That Means for Ro vs Hims)
This is the elephant in the room. Here's what actually happened, what it means, and how it changes this comparison.
The Timeline (Verified Events)
2023–2024
FDA declared semaglutide and tirzepatide in shortage. Under federal law, compounding pharmacies could produce copies. Companies like Hims offered compounded GLP-1s at a fraction of branded pricing.
February 21, 2025
The FDA resolved the semaglutide shortage. The legal basis for widespread compounding narrowed significantly.
April–May 2025
FDA enforcement discretion windows for compounders ended. Courts ruled compounders must stop making semaglutide products.
Late April 2025
Hims and Novo Nordisk initially partnered to offer branded Wegovy on Hims at $599/month. Hims continued offering compounded semaglutide alongside.
August 2025
Novo Nordisk terminated its initial partnership with Hims, citing concerns about continued marketing of compounded semaglutide.
December 22, 2025
FDA approves the oral Wegovy pill — the first oral GLP-1 for weight loss.
February 5–6, 2026
Hims announces a compounded oral semaglutide pill at ~$49/month. Novo Nordisk immediately threatens legal action. FDA announces intent to restrict APIs used in mass-marketed non-FDA-approved GLP-1 drugs.
February 7–9, 2026
Hims pulls the compounded oral pill. No pills shipped. Novo Nordisk files patent infringement lawsuit.
March 9, 2026
The pivot. Hims and Novo Nordisk announce new partnership: Hims stops advertising compounded GLP-1s, offers compounded semaglutide only on limited scale when clinically necessary, brings branded Ozempic and Wegovy (injectable and oral) to platform. Novo dismisses lawsuit.
What This Means If You're Choosing Between Ro and Hims Right Now
If you're currently on compounded semaglutide through Hims:
Hims says existing patients will have the opportunity to transition to FDA-approved medicines when determined clinically appropriate by their providers.
If you were choosing Hims mainly for the cheaper compounded price:
That option is narrowing significantly. Going forward, the real comparison for branded GLP-1s gets much tighter — and Ro's insurance concierge becomes a major differentiator.
If you're choosing Ro:
Less disruption. Ro's current public pricing already emphasizes FDA-approved branded options, and its pharmacy partnerships with NovoCare and LillyDirect are established.
The bottom line:
The real comparison going forward is: which platform gives you the best access to FDA-approved branded GLP-1s at the best total price? For people with insurance, that strongly favors Ro. For cash-pay users, the platforms are converging.
A Note on Safety
Compounded medications are prepared by pharmacies regulated at the state and federal level, but the finished products are not individually reviewed or approved by the FDA for safety, efficacy, or manufacturing quality. The FDA has raised concerns about potency variability between batches, sterility issues, and differences in the salt form of semaglutide used in some compounded products.
This does not mean compounded medications are inherently dangerous — many people have used them without incident. But the risk profile is different from FDA-approved products. If you're considering a compounded option, discuss it with your provider and ask whether the pharmacy provides certificates of analysis for each batch.
Insurance, HSA/FSA, and Reimbursement: Where Each Platform Wins
For many people, this single section will decide the entire comparison.
Ro's Insurance Advantage
The Ro Body membership itself is cash-pay only. However, Ro's insurance concierge can help determine coverage and handle prior authorization for eligible GLP-1 medication, which is billed separately through your pharmacy according to your plan.
Ro also offers a free GLP-1 insurance checker before you sign up — a personalized report on what your plan covers, your estimated copay, prior auth requirements, and medication supply — without any financial commitment.
Important caveat: Most insurance plans have strict requirements for GLP-1 coverage. You may need a BMI of 30+ (or 27+ with a weight-related condition), documented prior diet and exercise attempts, and sometimes a type 2 diabetes diagnosis. Prior authorization is almost always required. Ro helps navigate all of this — but approval isn't guaranteed.
Hims' No-Insurance-Needed Model
Hims is cash-pay only. Insurance cannot be used for any part of the service. For some people, this is actually a feature — you don't need to deal with prior authorization, coverage denials, or formulary restrictions. You pay the listed price, and you get the medication.
The tradeoff is obvious: you're paying full price regardless of what your insurance would cover.
When Insurance Makes Ro the Clear Winner
If you have commercial insurance from an employer, marketplace plan, or spouse's plan, check Ro first. Even if your plan doesn't end up covering GLP-1s, you'll know that before you commit. And if it does cover them, you could be looking at $149/month + a small copay vs. $599/month+ at Hims for the same FDA-approved Wegovy.
Is Hims or Ro Available in My State?
Ro
Ro says it provides services in all 50 states and Washington, D.C. However, specific treatments and medication availability can vary by state.
Hims
Hims is available in all 50 states as a telehealth platform, but GLP-1 treatments are not available everywhere. Compounded semaglutide eligibility lists 46 states plus D.C. — Alabama, Arkansas, Louisiana, and Mississippi are not on that list.
Our recommendation: Check Hims' state availability for your specific state and medication before you start comparing pricing.
How Each Program Works After You Sign Up
The Ro Body Program: Step by Step
- Start with the free insurance check (optional but recommended)
- Complete the online intake — health history, medications, weight, goals
- Provider review — licensed physician, eligibility within ~2 days
- Lab work — Quest Diagnostics metabolic testing included (at-home kit $75)
- Insurance concierge begins prior auth if applicable
- Medication ships — cash-pay under a week; insurance path ~2 weeks
- Ongoing: monthly check-ins, unlimited messaging, nurse coaching
Hims Weight Loss: Step by Step
- Complete the online assessment — fully online, some states require video visit
- Provider review — personalized treatment plan
- Choose your plan and pay — lower rates require longer commitments
- Medication ships — varies by medication and pharmacy
- Ongoing: 24/7 messaging, monthly check-ins, medication adjustments
- Anti-nausea medication (ondansetron) at no additional cost if prescribed
Support, Side Effects, and Medication Changes
The most commonly reported GLP-1 side effects include nausea, vomiting, diarrhea, constipation, and decreased appetite. These typically improve within a few weeks at each dose level. Serious side effects are less common but can include pancreatitis, gallbladder issues, and (rarely) thyroid concerns.
Ro's Support Model
Monthly structured check-ins with your provider, unlimited messaging, nurse coaching. Provider manages dose titration based on response and lab results.
Hims' Support Model
Unlimited online follow-ups and 24/7 messaging. Medication adjustments through the platform. Ondansetron included at no additional cost if needed — a genuine differentiator.
Ro is more structured: scheduled check-ins, labs tracking your progress, nurse coaching layered on top. Hims is more self-directed: you reach out when you need to, the app provides nutrition and behavioral tools. Neither platform replaces emergency medical care.
Which Is Easier to Cancel, Pause, or Leave?
This matters more than people think — especially when you're committing to a medication that might not agree with you.
Ro's Cancellation Policy
Month-to-month. Cancel at any time with 48 hours' notice before your next billing date. Membership fee for current period is nonrefundable once charged.
Maximum risk: one month's membership fee + medication already received.
Hims' Cancellation Policy
Cancel before next billing cycle with 48 hours' notice. Does not stop an order already processing. Refunds are not issued for prepaid months.
Maximum risk: full prepaid plan amount (e.g., $1,194 for 6-month compounded semaglutide).
If you're unsure whether GLP-1 treatment will work for you — or unsure about side effects — Ro's month-to-month model carries less financial risk. Hims' upfront model rewards commitment but punishes early exits.
Is Hims or Ro Legit? Safety and Verification Checklist
What Both Platforms Have in Common
Red Flags That Should Make You Walk Away from Any GLP-1 Provider
- No physician review before prescribing medication
- No questions about your medical history, current medications, or contraindications
- Claiming compounded products are "the same as" or "equivalent to" FDA-approved medications
- No way to contact a provider for side effects or emergencies
- No physical pharmacy address or license information available
- Pressure to buy before completing a medical evaluation
- Prices that seem impossibly low compared to every other provider
What Real Users Complain About Most
We reviewed public discussions and app store reviews to understand where each platform actually frustrates people. This isn't scientific — it's pattern recognition from what real users say publicly.
Common Ro Complaints
- Pricing confusion. The separate membership + medication model confuses people. "Wait, I'm paying $149/month AND medication on top?" is a common reaction.
- Affordability after intro pricing. Once intro pricing expires and doses escalate, some users find the total monthly cost unsustainable.
- Insurance navigation takes time. Prior authorization can take weeks, and some insurers ultimately deny coverage.
Common Hims Complaints
- Upfront payment commitment. Paying over a thousand dollars upfront for a multi-month plan is a real financial leap, especially before you know how the medication will affect you.
- Cancellation and refund friction. Some users report the cancellation process involves multiple steps, and prepaid months are nonrefundable.
- Medication transitions. As Hims moves away from compounded options, some users report uncertainty about next steps.
Every telehealth platform has negative reviews. Look for patterns, not individual stories. If the same complaint appears repeatedly, it's worth factoring in.
Ro vs Hims by Scenario: Find Yourself Fast
If you've read this far and still aren't sure, find your situation in this table.
| Your Situation | Better Fit | Why | Watch Out For |
|---|---|---|---|
| I have no insurance | Compare both | Hims for compounded (while available) or lower oral kit entry; Ro for branded cash-pay | Hims requires upfront payment; Ro adds membership fee |
| I might have insurance coverage | Ro | Free insurance checker, concierge handles prior auth | Membership fee applies even if insurance is denied |
| I want FDA-approved medication only | Ro | Current pricing page is entirely FDA-approved branded | Higher total cost than compounded alternatives |
| I'm open to compounded semaglutide | Hims | Lower price point, no membership | Narrowing availability; not FDA-approved; not in all states |
| I strongly prefer oral (no injections) | Both | Hims oral kits (not FDA-approved) or Ro Wegovy pill (FDA-approved) | Different products — oral kits are not GLP-1s |
| I want the lowest amount due today | Ro | First month is $39 + medication; monthly billing | Costs increase after month 1 |
| I can prepay to lock in lower monthly rate | Hims | Multi-month plans reduce monthly cost | No refunds if you quit early |
| I want the easiest exit if it doesn't work | Ro | Month-to-month billing, cancel with 48hrs notice | Still lose current month's membership fee |
| I care most about clinical support | Ro | Labs, nurse coaching, monthly check-ins, insurance concierge | Support adds value only if you use it |
| I want tirzepatide (Zepbound) specifically | Ro | Clear public Zepbound vial pricing through LillyDirect | Vials require drawing medication (not a pen) |
| I'm in AL, AR, LA, or MS | Ro | Hims compounded semaglutide not available in these states | Verify Ro availability for your specific treatment too |
Should You Consider Other GLP-1 Providers Instead?
Ro and Hims are two of the most visible options, but they're not the only ones. If neither fits your situation:
- LillyDirect: If you want Zepbound (tirzepatide) at the manufacturer's own pricing.
- NovoCare: Novo Nordisk's patient access program for Wegovy and Ozempic.
- Your doctor + insurance: If your insurance covers GLP-1s with a reasonable copay, traditional healthcare is almost always cheaper.
- Other telehealth providers: Companies like Eden, Found, WeightWatchers Clinic, Calibrate, and others compete with different pricing models.
See our full GLP-1 telehealth provider comparison for a broader view.
How We Evaluated Ro vs Hims
What We Checked
- • Official pricing pages on ro.co and hims.com — checked directly
- • Terms of service and cancellation policies — read in full
- • Support and FAQ pages — medication availability, state restrictions, insurance details, lab requirements
- • FDA resources — prescribing information, compounding guidance, Drug Shortage Database
- • Public discussion — Reddit, app store reviews, user forums for recurring complaint patterns
What We Weighted
| Factor | Weight | Reasoning |
|---|---|---|
| Real total cost | 30% | The #1 concern for most people |
| Medication path and options | 20% | What you're actually taking matters enormously |
| Insurance integration | 15% | Can change the cost equation by thousands |
| Clinical support quality | 10% | Affects safety, adherence, and outcomes |
| Cancellation and financial flexibility | 10% | How easily you can exit matters for first-timers |
| State availability | 5% | Deal-breaker if you're in an excluded state |
| Trust and quality signals | 10% | LegitScript status, pharmacy licensing, FDA approval status |
Our Affiliate Relationship
We have affiliate partnerships with both Ro and Hims. If you sign up through our links, we may earn a commission. This does not affect what you pay, and it does not determine our recommendation. We recommend the platform that fits each user scenario best, even when the recommendation that pays us less is the better choice for the reader.
GLP-1 pricing, availability, and regulations change frequently. We re-verify pricing at least monthly and update within 48 hours when major changes happen. Full editorial standards and how we rank.
Frequently Asked Questions: Ro vs Hims GLP-1
Final Verdict: Which One Deserves Your Money?
After verifying pricing, reading the terms, comparing medication options, and pressure-testing both platforms against real user scenarios — here's where we land:
Ro is the stronger choice if insurance is in play.
The free coverage checker alone is worth your time before you spend a dollar anywhere else. If your insurance covers even part of the medication, Ro's total cost drops below anything Hims can offer. Even for cash-pay users who want FDA-approved medications with lab testing and structured clinical support, Ro provides a comprehensive program — you're paying for it through that membership fee, but you're getting real clinical infrastructure in return.
Hims is the stronger choice for pure cash-pay simplicity.
No membership fee, bundled pricing, oral medication options (including non-GLP-1 kits that Ro doesn't offer), and anti-nausea medication included. If you know you're paying out of pocket and you want the most straightforward path, Hims delivers that. Just know that oral kits are compounded (not FDA-approved), and compounded semaglutide is being offered only on a limited scale going forward.
Neither is the right choice for everyone.
If your doctor can prescribe a covered GLP-1 cheaply, skip both. If you're on government insurance, neither can bill for it. And if you're uncomfortable with either the financial or medication commitment, a conversation with your healthcare provider is the right first step.
Not Sure Either Is Right?
Compare all verified GLP-1 providers for your situation
- Month-to-month options available
- Insurance navigation support
- Providers from $129/mo
- Side-by-side feature comparison